CACNA1C

Clinical trials for CACNA1C explained in plain language.

Never miss a new study

Get alerted when new CACNA1C trials appear

Sign up with your email to follow new studies for CACNA1C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First human trial aims to treat rare brain disorder in kids

Disease control Not yet recruiting

This early-stage trial tests a new drug called TS1-ASO in 5 children with Timothy Syndrome, a rare genetic condition affecting the heart and brain. The drug is given via spinal injection to see if it is safe and can improve or prevent developmental and behavioral problems. The st…

Matched conditions: CACNA1C

Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 12, 2026 12:09 UTC

CACNA1C

Get alerted when new CACNA1C trials appear

First human trial aims to treat rare brain disorder in kids